Article (Scientific journals)
In vitro Antileishmanial, Antitrypanosomal, and Anti-inflammatory- like Activity of Terminalia mollis Root Bark
Muganga, Raymond; Bero, Joanne; Quetin-Leclercq, Joelle et al.
2021In Planta Medica, efirst
Peer Reviewed verified by ORBi
 

Files


Full Text
pmE0327_wm.pdf
Publisher postprint (275.78 kB)
Request a copy
Full Text Parts
In vitro antileishmanial, antitrypanosomal and anti-inflammatory activity of Terminalia mollis root bark final version.docx
Author postprint (71.26 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] This study aims at determining the in vitro antitrypanosomal, antileishmanial, antioxidant, and anti-inflammatory-like activities of Terminalia mollis root crude extracts. The antitrypanosomal and antileishmanial activities on Trypanosoma brucei brucei (strain 427) and promastigotes of Leishmania mexicana mexicana (MHOM/BZ/84/BEL46) were evaluated in vitro. The methanolic root bark extract and standards were profiled by HPLC-PDA, and the majority of compounds identified using literature data. The in vitro antioxidant and anti-inflammatory-like activities were determined by evaluating the effect of crude extracts on reactive oxygen species produced by phorbol 12-myristate 13-acetate-stimulated equine neutrophils using lucigenin-enhanced chemiluminescence and on purified equine myeloperoxidase activity measured by specific immunological extraction followed by enzymatic detection. The methanolic, aqueous crude extract, and aqueous crude extract free of tannins exhibited good growth inhibition on Trypanosoma brucei brucei (IC50 3.72, 6.05, and 4.45 µg/mL respectively) but were inactive against Leishmania mexicana mexicana (IC50 > 100 µg/mL). Suramin (IC50 0.11 µg/mL) and amphotericin (IC50 0.11 µg/mL) were used as standard respectively for the antitrypanosomal and antileishmanial activity. Very interesting antioxidant and anti-inflammatory-like activities were observed with 50% hydroethanolic, aqueous crude extracts, and aqueous crude extract free of tannins as well as with pure punicalagin, gallic, and ellagic acid (IC50 0.38 – 10.51 µg/mL for 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid), chemiluminescence, and specific immunological extraction followed by enzymatic detection assays. The study results support traditional medicinal use of the plant for the treatment of parasitical disorders and revealed for the first time the antitrypanosomal potential, anti-inflammatory-like, and antioxidant activity of Terminalia mollis root.
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Muganga, Raymond
Bero, Joanne
Quetin-Leclercq, Joelle
Angenot, Luc  ;  Université de Liège - ULiège > Département de pharmacie > Département de pharmacie
Tits, Monique ;  Université de Liège - ULiège > Département de pharmacie > Département de pharmacie
Mouithys-Mickalad, Ange ;  Université de Liège - ULiège > Centre de l'oxygène : Recherche et développement (C.O.R.D.)
Franck, Thierry  ;  Université de Liège - ULiège > Centre de l'oxygène : Recherche et développement (C.O.R.D.)
Frederich, Michel  ;  Université de Liège - ULiège > Département de pharmacie > Pharmacognosie
Language :
English
Title :
In vitro Antileishmanial, Antitrypanosomal, and Anti-inflammatory- like Activity of Terminalia mollis Root Bark
Publication date :
2021
Journal title :
Planta Medica
ISSN :
0032-0943
eISSN :
1439-0221
Publisher :
Georg Thieme Verlag, Germany
Volume :
efirst
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 15 November 2020

Statistics


Number of views
90 (19 by ULiège)
Number of downloads
26 (16 by ULiège)

Scopus citations®
 
2
Scopus citations®
without self-citations
2
OpenCitations
 
0

Bibliography


Similar publications



Contact ORBi